首页 › 基金 › Sarissa Capital Management LP › VOR
Sarissa Capital Management LP 对 VOR 的持仓历史
VOR BIOPHARMA INC · 医疗保健
Sarissa Capital Management LP 在 Q3 2026 的 13F 申报中披露持有 VOR(VOR BIOPHARMA INC)25,399 股,市值约 US$485K,约占其申报组合的 0.32%,在其申报持仓中市值排名第 9 位。 Sarissa Capital Management LP 最近 13 个申报季度中有 13 个季度披露了 VOR 持仓,最早可追溯至 Q3 2023。
最后更新: 2026-11-17 · 来源: SEC EDGAR Form 13F-HR
Sarissa Capital Management LP 对 VOR 的持仓演变
Sarissa Capital Management LP 于 Q3 2023 首次披露 VOR 持仓:618,000 股(约 US$1.3M)。 该持仓在 Q1 2024 达到峰值 618,000 股,市值约 US$1.5M。 在 13 次申报中,Sarissa Capital Management LP 0 次增持、2 次减持、10 次保持不变。 最近一期申报(Q3 2026)显示持股 25,399 股、市值约 US$485K。 持仓曾出现大幅变动:Q3 2025 减持约 95% (随后一个季度股价下跌 73%)。
逐季持仓明细
| 季度 | 股数 | 金额 | 变化 |
|---|---|---|---|
| Q3 2023 | 618.00K | $1.31M | 新进 |
| Q4 2023 | 618.00K | $1.39M | 持有 |
| Q1 2024 | 618.00K | $1.46M | 持有 |
| Q2 2024 | 618.00K | $618.00K | 持有 |
| Q3 2024 | 618.00K | $432.60K | 持有 |
| Q4 2024 | 618.00K | $685.98K | 持有 |
| Q1 2025 | 508.02K | $364.50K | 减持 |
| Q2 2025 | 508.02K | $822.99K | 持有 |
| Q3 2025 | 25.40K | $1.24M | 减持 |
| Q4 2025 | 25.40K | $332.22K | 持有 |
| Q1 2026 | 25.40K | $453.12K | 持有 |
| Q2 2026 | 25.40K | $467.60K | 持有 |
| Q3 2026 | 25.40K | $484.61K | 持有 |
折线上的点按变动类型着色;缺失季度表示该季未申报持仓。
关于 VOR 与 13F 数据
VOR(VOR BIOPHARMA INC)属于医疗保健行业。我们追踪的基金中还有 71 只申报持有 VOR,申报仓位最大的包括:TCG Crossover Management, LLC (US$108.2M), RA CAPITAL MANAGEMENT, L.P. (US$85.9M), FCPM III SERVICES B.V. (US$65.0M)。 根据美国 SEC 规定,管理资产超过 1 亿美元的机构投资者须在每季度结束后 45 天内提交 13F 表,披露其美股多头持仓。该数据不包含空头、大部分期权及海外持仓,因此应将其视为季度快照而非实时仓位。
其它持有 VOR 的基金
- TCG Crossover Management, LLC 5.67M 股 · $108.24M · Q3 2026
- RA CAPITAL MANAGEMENT, L.P. 4.50M 股 · $85.93M · Q3 2026
- FCPM III SERVICES B.V. 3.41M 股 · $64.97M · Q3 2026
- Venrock Adviser, LLC 3.04M 股 · $58.04M · Q3 2026
- Frazier Life Sciences Management, L.P. 2.74M 股 · $52.35M · Q3 2026
- Caligan Partners LP 1.93M 股 · $36.73M · Q3 2026
- GREAT POINT PARTNERS LLC 1.13M 股 · $21.50M · Q3 2026
- Nantahala Capital Management, LLC 931.64K 股 · $17.78M · Q3 2026
- Paradigm Biocapital Advisors LP 889.58K 股 · $16.97M · Q3 2026
- NAN FUNG TRINITY (HK) Ltd 721.55K 股 · $13.77M · Q3 2026
- NEXTBio Capital Management LP 620.93K 股 · $11.85M · Q3 2026
- Rosalind Advisors, Inc. 609.20K 股 · $11.62M · Q3 2026
更多关于 Sarissa Capital Management LP
常见问题
How long has Sarissa Capital Management LP held VOR?
Sarissa Capital Management LP has disclosed VOR holdings in 13 of the last 13 reported quarters, going back to Q3 2023.
What is Sarissa Capital Management LP's current position in VOR?
As of Q3 2026, Sarissa Capital Management LP holds 25.40K shares of VOR (VOR BIOPHARMA INC), valued at $484.61K, representing 0.32% of its reported portfolio and ranking #9.
Has Sarissa Capital Management LP been buying or selling VOR?
In the latest 13F filing (Q3 2026), Sarissa Capital Management LP held unchanged its position in VOR. The position peaked in Q1 2024 at 618.00K shares.
Which other funds hold VOR?
Other major institutional holders of VOR include TCG Crossover Management, LLC, RA CAPITAL MANAGEMENT, L.P., FCPM III SERVICES B.V., among 71 funds with disclosed positions.
Where does this data come from?
All figures are computed from SEC Form 13F quarterly filings, which institutional investment managers must file within 45 days of quarter end for long positions of $100,000 or more.